These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 21743321)
1. Dendritic cells at the interface of innate and adaptive immunity to HIV-1. Smed-Sörensen A; Loré K Curr Opin HIV AIDS; 2011 Sep; 6(5):405-10. PubMed ID: 21743321 [TBL] [Abstract][Full Text] [Related]
2. Innate signaling in HIV-1 infection of dendritic cells. van der Vlist M; van der Aar AM; Gringhuis SI; Geijtenbeek TB Curr Opin HIV AIDS; 2011 Sep; 6(5):348-52. PubMed ID: 21743322 [TBL] [Abstract][Full Text] [Related]
3. Natural killer cells, dendritic cells, and the alarmin high-mobility group box 1 protein: a dangerous trio in HIV-1 infection? Gougeon ML; Bras M Curr Opin HIV AIDS; 2011 Sep; 6(5):364-72. PubMed ID: 21825870 [TBL] [Abstract][Full Text] [Related]
4. Innate immunity and chronic immune activation in HCV/HIV-1 co-infection. Gonzalez VD; Landay AL; Sandberg JK Clin Immunol; 2010 Apr; 135(1):12-25. PubMed ID: 20100670 [TBL] [Abstract][Full Text] [Related]
6. Innate immunity in the control of HIV/AIDS: recent advances and open questions. Ploquin MJ; Jacquelin B; Jochems SP; Barré-Sinoussi F; Müller-Trutwin MC AIDS; 2012 Jun; 26(10):1269-79. PubMed ID: 22472855 [TBL] [Abstract][Full Text] [Related]
7. HIV-1 Tat addresses dendritic cells to induce a predominant Th1-type adaptive immune response that appears prevalent in the asymptomatic stage of infection. Fanales-Belasio E; Moretti S; Fiorelli V; Tripiciano A; Pavone Cossut MR; Scoglio A; Collacchi B; Nappi F; Macchia I; Bellino S; Francavilla V; Caputo A; Barillari G; Magnani M; Laguardia ME; Cafaro A; Titti F; Monini P; Ensoli F; Ensoli B J Immunol; 2009 Mar; 182(5):2888-97. PubMed ID: 19234184 [TBL] [Abstract][Full Text] [Related]
8. Innate and adaptive immune pathways to tolerance. Thornton CA; Morgan G Nestle Nutr Workshop Ser Pediatr Program; 2009; 64():45-57; discussion 57-61, 251-7. PubMed ID: 19710514 [TBL] [Abstract][Full Text] [Related]
9. Natural killer cells in HIV-1 infection: a double-edged sword. Funke J; Dürr R; Dietrich U; Koch J AIDS Rev; 2011; 13(2):67-76. PubMed ID: 21587340 [TBL] [Abstract][Full Text] [Related]
10. HIV-1 reactivation in HIV-latently infected dendritic cells by oral microorganisms and LPS. Huang CB; Alimova YV; Ebersole JL Cell Immunol; 2011; 268(2):105-11. PubMed ID: 21420664 [TBL] [Abstract][Full Text] [Related]
12. A look at HIV journey: from dendritic cells to infection spread in CD4⁺ T cells. Blanchet F; Moris A; Mitchell JP; Piguet V Curr Opin HIV AIDS; 2011 Sep; 6(5):391-7. PubMed ID: 21743320 [TBL] [Abstract][Full Text] [Related]
13. CD4+ blood dendritic cells are potent producers of IFN-alpha in response to in vitro HIV-1 infection. Ferbas JJ; Toso JF; Logar AJ; Navratil JS; Rinaldo CR J Immunol; 1994 May; 152(9):4649-62. PubMed ID: 7908920 [TBL] [Abstract][Full Text] [Related]
14. HIV-infected cells are major inducers of plasmacytoid dendritic cell interferon production, maturation, and migration. Schmidt B; Ashlock BM; Foster H; Fujimura SH; Levy JA Virology; 2005 Dec; 343(2):256-66. PubMed ID: 16278001 [TBL] [Abstract][Full Text] [Related]
15. Systemic mobilization of antigen presenting cells, with a chimeric Flt-3 and G-CSF receptor agonist, during immunization of Macaca mulatta with HIV-1 antigens is insufficient to modulate immune responses or vaccine efficacy. Koopman G; Mortier D; Niphuis H; Farese AM; Kahn LE; Mann D; Wagner R; MacVittie TJ; Woulfe SL; Heeney JL Vaccine; 2005 Jul; 23(33):4195-202. PubMed ID: 15896883 [TBL] [Abstract][Full Text] [Related]
16. Zoledronic acid and interleukin-2 treatment improves immunocompetence in HIV-infected persons by activating Vgamma9Vdelta2 T cells. Poccia F; Gioia C; Martini F; Sacchi A; Piacentini P; Tempestilli M; Agrati C; Amendola A; Abdeddaim A; Vlassi C; Malkovsky M; D'Offizi G AIDS; 2009 Mar; 23(5):555-65. PubMed ID: 19238075 [TBL] [Abstract][Full Text] [Related]
17. Distinctive TLR7 signaling, type I IFN production, and attenuated innate and adaptive immune responses to yellow fever virus in a primate reservoir host. Mandl JN; Akondy R; Lawson B; Kozyr N; Staprans SI; Ahmed R; Feinberg MB J Immunol; 2011 Jun; 186(11):6406-16. PubMed ID: 21515797 [TBL] [Abstract][Full Text] [Related]
18. Normal immune function of monocyte-derived dendritic cells from HIV-infected individuals: implications for immunotherapy. Chougnet C; Cohen SS; Kawamura T; Landay AL; Kessler HA; Thomas E; Blauvelt A; Shearer GM J Immunol; 1999 Aug; 163(3):1666-73. PubMed ID: 10415073 [TBL] [Abstract][Full Text] [Related]
19. Increased IFN-gamma production by NK and CD3+/CD56+ cells in sexually HIV-1-exposed but uninfected individuals. Montoya CJ; Velilla PA; Chougnet C; Landay AL; Rugeles MT Clin Immunol; 2006 Aug; 120(2):138-46. PubMed ID: 16624619 [TBL] [Abstract][Full Text] [Related]
20. In vitro human immunodeficiency virus eradication by autologous CD8(+) T cells expanded with inactivated-virus-pulsed dendritic cells. Lu W; Andrieu JM J Virol; 2001 Oct; 75(19):8949-56. PubMed ID: 11533158 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]